Literature DB >> 10697544

Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines.

A Lokshin1, H Zhang, J Mayotte, M Lokshin, M L Levitt.   

Abstract

BACKGROUND: Retinoids represent a potentially useful class of drugs in the chemoprevention and treatment of cancer, due to their ability to regulate cell proliferation and differentiation. However, there is controversy in the literature about the effects of all-trans retinoic acid (ATRA) in non- small cell lung cancer (NSCLC). In this study we examined the effects of ATRA on apoptotic death in NSCLC.
MATERIALS AND METHODS: Cell proliferation was determined by thymidine incorporation in cultured NSCLC cells. DNA fragmentation was measured in NSCLC cell lines as a marker of apoptosis. The expression of keratinocyte transglutaminase and cytokeratin 10 were measured as markers of squamous differentiation.
RESULTS: ATRA inhibited cell proliferation, and induced markers of both apoptosis and squamous differentiation after 24-48 hrs of treatment.
CONCLUSIONS: These results indicate the possibility of the early growth-inhibitory and apoptotic effects of ATRA in NSCLC which may result in selection of ATRA-resistant cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10697544

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Characterization and functional analysis of the human microRNA let-7a2 promoter in lung cancer A549 cell lines.

Authors:  Hengyun Guan; Pengju Zhang; Chang Liu; Ju Zhang; Zhaoqin Huang; Weiwen Chen; Zhaobo Chen; Nana Ni; Qingwei Liu; Anli Jiang
Journal:  Mol Biol Rep       Date:  2011-03-02       Impact factor: 2.316

Review 2.  Chemoprevention of carcinoma prostate: a review.

Authors:  M S Ansari; N P Gupta; A K Hemal
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

3.  Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro.

Authors:  Eun Jung Choi; Young Mi Whang; Seok Jin Kim; Hyun Jin Kim; Yeul Hong Kim
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.